Saxton discusses classical program-planning theory gap

Share this article:
“[Med ed] Planners must learn how to balance stakeholder interests by applying democratic principles in negotiating educational, political, and program outcomes,” wrote Mike Saxton, Pfizer CME director, in a JCEHP review about the gap between classical program-planning theory and its application.

Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.